This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,430.17 firm-fixed-price contract is for the delivery of 90-count bottles of the medication Daliresp 500 MCG Tablet. The contract has a period of performance through May 8, 2025 and was awarded on May 7, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This delivery order is part of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Daliresp 500mcg 90s medication. The contract has a ceiling value of $41,684.33 and a performance period through May 30, 2025. It is a firm-fixed-price delivery order contract, which indicates a pre-determined price for the medication. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Daliresp 500 MCG tablets. The contract has a ceiling value of $1,869.98 and a completion date of November 27, 2024. It is a firm fixed-price contract type. This order is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Daliresp 500 mcg tablets. The contract has a ceiling value of $1,704.32 and runs through February 10, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90 tablet bottles of the medication DALIRESP 500 MCG, with a ceiling value of $5,015.42. The contract is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product, with a ceiling value of $12,941.28 and a period of performance through May 14, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, valued at $3,044.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,093,224 units of Daliresp 500 MCG tablets in a 90-count package. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a period of performance ending on May 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,989.26 and a period of performance through June 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a $14,463.43 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 29, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Daliresp 500 MCG tablets. The contract has a ceiling value of $13,413.84 and is set to expire on August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these pharmaceutical products to support military treatment facilities and other federal healthcare providers. The contract is a firm-fixed-price delivery order, which is a common...